Unlock instant, AI-driven research and patent intelligence for your innovation.

Pharmaceutical compositions comprising glutathione and uses thereof

A technology of glutathione and composition, applied in the field of medicine and biology, can solve the problems of implant failure, poor implant repair, high initial osseointegration, etc., and achieve a significant synergistic effect

Active Publication Date: 2017-02-01
DALIAN UNIV
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The implant restoration of diabetic patients often has poor initial osseointegration and high failure rate. Diabetic patients whose condition is not well controlled are prone to implant failure

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Example 1 Effects of a pharmaceutical composition comprising GSH on the differentiation and proliferation of human osteoblast-like MG-63 cells under high glucose

[0025] MG-63 cells were cultured in MEM / EBSS medium (containing 10% fetal bovine serum (FBS) and non-essential amino acids (NEAA)) in culture flasks. The cells were passaged when the adherent confluence reached about 80-90% in the culture flask. MG-63 cells were seeded in 96-well plates at 2000 cells / well and cultured for 24 hours. After 12 hours of serum starvation, the medium was replaced with one of the following: (a) MEM / EBSS (containing NEAA, 5% FBS and 1.0 g / L glucose (physiological glucose concentration, NG)); (b) MEM / EBSS (containing NEAA, 5% FBS and 4.5 g / L glucose (high glucose concentration, HG)); supplemented medium with GSH and GSH-containing For the culture medium solution of the pharmaceutical composition, in each group, the control group was supplemented with medium a, the model group and th...

Embodiment 2

[0036] Example 2 Preparation of slow-release microspheres

[0037] Dissolve 100 mg of PLA in 1 ml of dichloromethane to make an organic phase, then add 0.1 ml of drug solution (30 mg / ml) to the organic phase, and ultrasonically (190 kW) to form colostrum; pour the colostrum into 8 ml with a concentration of 1% PVA aqueous solution, stirred at 1500rpm to form a double emulsion, then poured 7ml of PVA aqueous solution, placed on a mechanical stirrer and stirred at 600rpm for 6-8 hours, after the dichloromethane was completely volatilized, centrifuged to collect the obtained The microspheres were washed several times with distilled water, then collected by centrifugation, filtered through a Buchner leak, and freeze-dried to obtain slow-release microspheres.

[0038] Through the above-mentioned method, the present invention has prepared 5 groups of microspheres respectively, and the weight ratio of the drug composition of each group is as follows:

[0039] Weight ratio ...

Embodiment 3

[0040] Example 3 Study on the effect of slow-release microspheres on the osseointegration level around implants in type 2 diabetic rats

[0041] 8-week-old GK rats were adaptively fed for one week, and continuously fed with high-fat and high-sugar diet for 4 weeks. The rats with blood glucose 18.0 mmol / L were excluded by monitoring the blood glucose of the rats, thereby reducing type 2 DM. The mixed bias of rat blood glucose values ​​in this experiment ensures the smooth progress of the experiment.

[0042] The rats were successfully anesthetized with 2% sodium pentobarbital. After anesthesia, the skin of the right lower limb of the rat was prepared. A longitudinal incision of about 2 cm in length was made along the tibia at the femoral head of the right lower limb of the rat, and the muscle tissue was bluntly separated. Tendon and periosteum were exposed, and the tibial epiphysis was exposed. Circular dental drills with diameters of 2.2 mm and 2.8 mm were used to prepare imp...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

The invention belongs to the field of medicine bioengineering and particularly relates to a drug composition containing glutathione (GSH) and an application of the drug composition. More particularly, the invention provides an application of reduced GSH to preparation of drugs for promoting diabetic implant bone integration, and further provides the drug composition containing GSH. The drug composition can promote diabetic implant bone integration and comprises GSH and other drugs, wherein the other drugs are preferably selected from resveratrol and / or insulin. Furthermore, the invention provides a drug preparation containing the drug composition and a preparation method of the drug preparation; the drug preparation is preferably selected from sustained-release microspheres.

Description

technical field [0001] The invention belongs to the field of medical biology, and in particular relates to a pharmaceutical composition containing glutathione and use thereof. Background technique [0002] Diabetes mellitus is a common endocrine and metabolic disease, which is a systemic chronic metabolic syndrome characterized by the increase of blood sugar and urine sugar caused by absolute or relative insulin deficiency and leads to sugar, protein and fat metabolism disorders. At present, the number of diabetic patients in China has reached 50 million, accounting for one-fifth of the world's total diabetes population. The prevalence rate ranks second in the world after India, and the rate of increase is at least 3,000 per day, and an annual increase of more than 1.2 million. Type 2 diabetes mellitus (T2DM) is the main type of diabetes, accounting for more than 90% of all diabetic patients. With the development of economy and the aging of society, the prevalence of T2DM i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K38/06A61K38/28A61K9/16A61K47/34A61P19/08A61K31/05
Inventor 张静莹
Owner DALIAN UNIV